Skip to main content
. 2023 May 16;15(5):e39100. doi: 10.7759/cureus.39100

Table 5. Therapies in the population.

NSAIDs: non-steroidal anti-inflammatory drugs; csDMARDs: conventional synthetic disease-modifying antirheumatic drugs

Parameters Early-onset SpA (N=163) Late-onset SpA (N=31) p
NSAIDs N (%) 75 (46) 8 (25) 0.08
Analgesics N (%) 16(9.8) 3(9.6) 0.54
csDMARDs N (%) 90 (55.21) 17 (54.83) 0.66
Corticosteroids N (%) 34 (20.8) 9(29) 0.40